← All companies

DBVT

DBV TECHNOLOGIES

DBVTF Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$4.26

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$1.26B

Revenue (TTM)

$4.94M

Net income (TTM)

-$176M

EPS (TTM)

$-0.71

P/E ratio

—

Dividend yield

—

Free cash flow

-$122M

Cash

$175M

Total assets

$223M

Gross margin

—

52-week range

—

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Jul 16, 2026 10-Q Quarter ended 2026-06-30 Jul 16, 2026 8-K Other events Jun 29, 2026 8-K Director or officer change Jun 5, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 3, 2026 8-K Director or officer change May 5, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Results of operations (earnings release) Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Other events Mar 2, 2026 8-K Other events Jan 20, 2026 8-K Other events Dec 16, 2025 8-K Director or officer change; Regulation FD disclosure Oct 30, 2025 8-K Results of operations (earnings release) Oct 29, 2025 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Director or officer change; Regulation FD disclosure Sep 18, 2025 8-K Other events Sep 5, 2025 8-K Results of operations (earnings release) Jul 29, 2025 10-Q Quarter ended 2025-06-30 Jul 29, 2025 8-K Other events Jun 25, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 11, 2025 10-K/A Fiscal year ended 2024-12-31 May 14, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Apr 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 31, 2025 8-K Results of operations (earnings release); Other events Mar 24, 2025 8-K Regulation FD disclosure Jan 8, 2025 8-K Director or officer change Dec 18, 2024 8-K Delisting notice or listing-rule failure Dec 16, 2024 8-K Regulation FD disclosure Dec 11, 2024 8-K Modified rights of security holders; Regulation FD disclosure Nov 12, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Other events Oct 22, 2024 8-K Other events Sep 23, 2024 8-K Results of operations (earnings release) Jul 30, 2024